Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Lumos Pharma Inc (LUMO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Lumos Pharma Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.90 -0.04    -0.48%
10:15:17 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  US55028X1090 
CUSIP:  55028X109
  • Volume: 1,652
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 7.90 - 8.02
Lumos Pharma Inc 7.90 -0.04 -0.48%
Start Date Username Call Open Rate End Date Chg. %
Feb 24, 2022 Chris Wuchte   9.84 Mar 18, 2022 @ 9.62 -2.24%
Aug 17, 2021 patrick le goff   8.54 Sep 10, 2021 @ 11.19 +31.03%
Aug 17, 2021 Robbert Kuipers   8.51 Aug 23, 2021 @ 9.23 +8.46%
Aug 17, 2021 Robbert Kuipers   8.51 Aug 23, 2021 @ 9.23 +8.46%
Aug 11, 2021 mobarak alhajri   7.46 Sep 03, 2021 @ 11.35 +52.14%
Aug 02, 2021 EY EY   7.75 Aug 27, 2021 @ 10.52 +35.74%
Jul 23, 2021 Steffen Keller   7.80 Aug 13, 2021 @ 7.83 +0.38%
Jul 21, 2021 Sergio Llampallas   8.30 Aug 13, 2021 @ 7.83 -5.66%
Jul 16, 2021 Jorge Martin   9.67 Aug 06, 2021 @ 7.39 -23.58%
Jun 09, 2021 James Bizzarro   11.08 Jul 02, 2021 @ 10.20 -7.91%
Jun 07, 2021 Jorge Martin   10.36 Jul 02, 2021 @ 10.20 -1.50%
Mar 24, 2021 Jorge Martin   13.50 Apr 16, 2021 @ 12.07 +10.59%
Mar 24, 2021 נאור נעלי   14.27 Mar 29, 2021 @ 11.40 -20.11%
Mar 23, 2021 רונן בן חמו   12.41 Apr 16, 2021 @ 12.07 -2.74%
Mar 23, 2021 יוני ליבוביץ   12.64 Mar 29, 2021 @ 11.40 -9.81%
Mar 23, 2021 יוני ליבוביץ   12.64 Mar 29, 2021 @ 11.40 -9.81%
Mar 22, 2021 גבריאל מלול   13.54 Apr 16, 2021 @ 12.07 -10.86%
Mar 19, 2021 Mohamed Ali Sghairi   12.63 Apr 09, 2021 @ 11.27 -10.77%
Mar 16, 2021 Angel Corredera   13.15 Mar 19, 2021 @ 13.06 -0.68%
Mar 16, 2021 Павел Говорушко   13.40 Apr 09, 2021 @ 11.27 -15.90%
Dec 16, 2020 Mor Fink   21.70 Dec 16, 2020 @ 20.19 +6.96%
Dec 16, 2020 Иван Сидоров   20.14 Jan 08, 2021 @ 22.16 -10.03%
Nov 30, 2020 Gregorio Cavallaro   14.99 Dec 25, 2020 @ 28.78 +91.99%
Nov 18, 2020 Vellu Lahtinen   15.98 Dec 11, 2020 @ 17.36 +8.64%
Nov 09, 2020 mario simoes   14.99 Dec 04, 2020 @ 16.02 +6.87%
Oct 08, 2020 Kaousias Kostas   14.10 Oct 30, 2020 @ 14.65 +3.90%
Jul 15, 2020 mario simoes   14.20 Aug 07, 2020 @ 15.15 +6.69%
Jun 22, 2020 Pedro Pardo   16.29 Jul 17, 2020 @ 15.72 -3.50%
May 19, 2020 Yogesh Surve   13.83 May 20, 2020 @ 13.38 -3.25%
May 12, 2020 mario simoes   11.41 Jun 05, 2020 @ 13.75 +20.51%
Apr 14, 2020 Farzana Gul   9.03 May 08, 2020 @ 10.15 -12.40%
Mar 12, 2020 Andreas Schatz   10.13 Apr 03, 2020 @ 7.78 -23.20%
Feb 28, 2020 SUHAIL MUSTAFA   1.40 Mar 20, 2020 @ 0.89 +36.43%
Feb 18, 2020 mario simoes   1.63 Mar 13, 2020 @ 1.14 -30.06%
Jan 17, 2020 mario simoes   1.98 Feb 07, 2020 @ 1.66 -16.16%
Jan 02, 2020 SUHAIL MUSTAFA   2.24 Jan 24, 2020 @ 1.82 +18.75%
Dec 31, 2019 Samer Khoury   2.64 Jan 24, 2020 @ 1.82 -31.06%
Dec 30, 2019 Henri Pylsy   2.34 Jan 24, 2020 @ 1.82 +22.22%
Dec 30, 2019 Sebastiaan Seghers   2.37 Jan 24, 2020 @ 1.82 -23.21%
Dec 30, 2019 shay levi   2.48 Jan 24, 2020 @ 1.82 -26.61%
Dec 30, 2019 SUHAIL MUSTAFA   2.42 Jan 02, 2020 @ 2.31 +4.55%
Dec 27, 2019 SUHAIL MUSTAFA   2.86 Dec 30, 2019 @ 2.32 +18.88%
Dec 26, 2019 Aeraj Patel   3.05 Jan 17, 2020 @ 2.04 -33.11%
Dec 26, 2019 davide garulli   3.17 Jan 17, 2020 @ 2.04 +35.65%
Dec 24, 2019 davide garulli   2.34 Dec 26, 2019 @ 2.33 +0.43%
Dec 20, 2019 Arbi nazri   1.84 Jan 10, 2020 @ 2.10 +14.13%
Dec 20, 2019 Guilherme Ribeiro   1.94 Jan 10, 2020 @ 2.10 +8.25%
Dec 20, 2019 Santi Vila Turon   2.11 Jan 10, 2020 @ 2.10 -0.47%
Dec 12, 2019 Jeremy Swainston   1.60 Jan 03, 2020 @ 2.21 -38.12%
Dec 11, 2019 Mohammed Aljowaiber   1.65 Jan 03, 2020 @ 2.21 +33.94%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

LUMO Comments

Write your thoughts about Lumos Pharma Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Episcopolian OptionTrader
Episcopolian1 Oct 10, 2017 9:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$NLNK Indoximod + gemcitabine and nab-paclitaxel for Pancreatic cancer. Phase 2 data due anytime now. I bought upside calls $20
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email